Clinical Trial Update: Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dihydroartemisinin plus piperaquine for malaria prevention in forest rangers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Dihydroartemisinin (dihydroartemisinin)
• Piperaquine (Piperaquine)

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Malaria | Phase 4 | Status: COMPLETED